Claire Friedman, MD - MSK Gynecologic Oncologist & Early Drug Development Specialist

Claire Friedman, MD - Gynecologic Oncologist and Early Drug Development Specialist Dr. Claire Friedman is a distinguished gynecologic oncologist based in Manhattan, New York, specializing in the treatment of cancers affecting the female reproductive system. With a robust academic background and extensive clinical experience, Dr. Friedman is dedicated to providing personalized care to her patients while advancing the field of gynecologic oncology through innovative research and early drug development. Expertise and Specialization Dr. Friedman holds both an MD and an MS degree, equipping her with a comprehensive understanding of both clinical practice and medical research. Her specialization in gynecologic oncology allows her to focus on various cancers, including ovarian, uterine, cervical, and vulvar cancers. She employs cutting-edge diagnostic techniques and treatment modalities tailored to each patient's unique needs. One of Dr. Friedman's key areas of expertise is early drug development. This involves working closely with pharmaceutical companies and research institutions to evaluate new therapeutic agents that may improve outcomes for patients with gynecologic malignancies. By participating in clinical trials, she not only contributes to the advancement of cancer treatment but also provides her patients access to the latest therapies that may not yet be widely available. Patient-Centered Care At her practice, Dr. Friedman emphasizes a patient-centered approach that prioritizes open communication and shared decision-making. She understands that a cancer diagnosis can be overwhelming for patients and their families; therefore, she strives to create a supportive environment where patients feel empowered to ask questions and express their concerns. Dr. Friedman takes the time to explain complex medical information in understandable terms, ensuring that her patients are fully informed about their diagnosis and treatment options. This collaborative approach fosters trust between Dr. Friedman and her patients, which is crucial for effective treatment outcomes. Commitment to Research In addition to her clinical responsibilities, Dr. Friedman is actively involved in research initiatives aimed at improving cancer therapies for women. Her work often focuses on identifying biomarkers that can predict how well a patient will respond to specific treatments or understanding the genetic factors that contribute to gynecologic cancers. By staying at the forefront of scientific advancements, Dr. Friedman ensures that her practice incorporates evidence-based medicine into everyday patient care. Her contributions to peer-reviewed journals further solidify her reputation as a leader in the field of gynecologic oncology. Location and Accessibility Located conveniently in Manhattan, Dr. Friedman's practice is accessible for both local residents and those traveling from surrounding areas seeking specialized care in gynecologic oncology. The office is equipped with state-of-the-art technology designed to facilitate comprehensive evaluations and treatments. Patients can expect a warm welcome from a dedicated staff committed to making each visit as comfortable as possible. From initial consultations through ongoing follow-up care, Dr. Friedman's team works diligently to support every aspect of the patient's journey through cancer treatment. In summary, Dr. Claire Friedman stands out as an exceptional gynecologic oncologist who combines clinical excellence with groundbreaking research efforts aimed at improving women's health outcomes in oncology. Information about Dr. Claire Friedman’s specialties can be found on Manhattan NYC. ↩